Patents by Inventor Adam J. Yestrepsky

Adam J. Yestrepsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230111731
    Abstract: A method can comprise advancing a suction cup at a distal end of a suction catheter into a heart chamber, contacting the suction cup to a heart valve leaflet, and partially axially collapsing the suction cup while applying a negative pressure through the suction catheter and the suction cup and contacting the suction cup to the heart valve leaflet.
    Type: Application
    Filed: December 15, 2022
    Publication date: April 13, 2023
    Inventors: Yaron Keidar, Adam J. Yestrepsky
  • Patent number: 11571216
    Abstract: Aortic occlusion and embolic protection devices include radially expandable and collapsible proximal and distal end portions, such as annular self-expanding stents or frames, that are configured to radially expand within an aorta to secure the device within the aorta. The devices can also include a catheter extending axially between the distal end portion and the proximal end portion and a porous covering, or filter, positioned around the catheter and between the proximal end portion and the distal end portion and configured to filter emboli from blood flowing into upper-body arteries. The device can further include a one-way valve positioned at or adjacent to the distal end portion of the device and configured to restrict retrograde blood flow through the device toward the heart.
    Type: Grant
    Filed: May 28, 2020
    Date of Patent: February 7, 2023
    Assignee: Edwards Lifesciences Corporation
    Inventors: Mark M. Dehdashtian, Teodoro S. Jimenez, Nathan Satter, Fabian Daniel Schroeder, Raffaele Mazzei, Jeff Kosmoski, Shahram Zamani, Adam J. Yestrepsky
  • Patent number: 11529233
    Abstract: Methods and devices for the treatment of cardiac valve dysfunction through the placement of lines and anchors. The lines and anchors can form artificial chordae between valve leaflets and the ventricular wall or papillary muscles or connect the two valve leaflets together. The methods and devices offer a mechanism for performing this technique with the heart still beating, and allows for the placement of multiple lines with a single device.
    Type: Grant
    Filed: April 17, 2020
    Date of Patent: December 20, 2022
    Assignee: Edwards Lifesciences Corporation
    Inventors: Yaron Keidar, Adam J. Yestrepsky
  • Publication number: 20220387766
    Abstract: An aortic occlusion and perfusion device includes an expandable member configured to expand within the aorta. A catheter extends proximally from the expandable member in fluid communication with the expandable member. The catheter defines openings through which blood can pass with one or more of the openings located proximal to the expandable member and one or more of the openings located within the expandable member. The catheter defines a lumen in fluid communication with the one or more openings located within the expandable member, the lumen terminating at a terminus such that the lumen is not in fluid communication with a distal end portion of the catheter. A flow control sheath is disposed around the catheter proximal to the expandable member such that axial movement of the flow control sheath relative to the catheter selectively occludes or uncovers the one or more openings located proximal to the expandable member.
    Type: Application
    Filed: August 12, 2022
    Publication date: December 8, 2022
    Inventors: Kenneth Eliasen, Adam J. Yestrepsky
  • Patent number: 11413434
    Abstract: An aortic occlusion and perfusion device includes an expandable member configured to expand within the aorta to secure the device within the aorta, and a catheter extending proximally from the expandable member and in fluid communication with the expandable member. The catheter can define a plurality of openings along its length through which blood can pass with one or more of the openings located proximal to the expandable member and one or more of the openings located within the expandable member. The device can also include a flow control sheath disposed around the catheter member such that axial movement of the flow control sheath relative to the catheter selectively occludes or uncovers one or more of the openings located proximal to the expandable member.
    Type: Grant
    Filed: June 24, 2019
    Date of Patent: August 16, 2022
    Assignee: Edwards Lifesciences Corporation
    Inventors: Kenneth Eliasen, Adam J. Yestrepsky
  • Publication number: 20220218483
    Abstract: A tissue anchor delivery includes comprises a needle including a hollow shaft portion, a tip portion, and an outlet opening. The tissue anchor delivery device further includes a plurality of tissue anchors disposed within the shaft portion of the needle and a suture coupled to each of the plurality of tissue anchors and disposed at least partially within the shaft portion of the needle.
    Type: Application
    Filed: March 28, 2022
    Publication date: July 14, 2022
    Inventors: Sven Benjamin Iversen, Adam J. Yestrepsky, Amy E. Munnelly, Bin Tian, Danny Barrientos Baldo, Brian S. Conklin, Louis A. Campbell, John Richard Carpenter, Derrick Johnson
  • Patent number: 11285004
    Abstract: A method for repairing a native valve of a patient during a non-open-heart procedure includes attaching two or more attachment members to the native valve. The method also includes applying a force to the two or more attachment members such that the two or more attachment members cause a cinching effect on at least a portion of the native valve. The method further includes securing the two or more attachment members with one or more anchor members such that the two or more attachment members maintain the cinching effect.
    Type: Grant
    Filed: June 3, 2019
    Date of Patent: March 29, 2022
    Assignee: Edwards Lifesciences Corporation
    Inventors: Sven Benjamin Iversen, Adam J. Yestrepsky, Amy E. Munnelly, Bin Tian, Danny Barrientos Baldo, Jr., Brian S. Conklin, Louis A. Campbell, John Richard Carpenter, Derrick Johnson
  • Publication number: 20200289123
    Abstract: Aortic occlusion and embolic protection devices include radially expandable and collapsible proximal and distal end portions, such as annular self-expanding stents or frames, that are configured to radially expand within an aorta to secure the device within the aorta. The devices can also include a catheter extending axially between the distal end portion and the proximal end portion and a porous covering, or filter, positioned around the catheter and between the proximal end portion and the distal end portion and configured to filter emboli from blood flowing into upper-body arteries. The device can further include a one-way valve positioned at or adjacent to the distal end portion of the device and configured to restrict retrograde blood flow through the device toward the heart.
    Type: Application
    Filed: May 28, 2020
    Publication date: September 17, 2020
    Inventors: Mark M. Dehdashtian, Teodoro S. Jimenez, Nathan Satter, Fabian Daniel Schroeder, Raffaele Mazzei, Jeff Kosmoski, Shahram Zamani, Adam J. Yestrepsky
  • Publication number: 20200237513
    Abstract: Methods and devices for the treatment of cardiac valve dysfunction through the placement of lines and anchors. The lines and anchors can form artificial chordae between valve leaflets and the ventricular wall or papillary muscles or connect the two valve leaflets together. The methods and devices offer a mechanism for performing this technique with the heart still beating, and allows for the placement of multiple lines with a single device.
    Type: Application
    Filed: April 17, 2020
    Publication date: July 30, 2020
    Inventors: Yaron Keidar, Adam J. Yestrepsky
  • Patent number: 10667821
    Abstract: Embodiments of aortic occlusion devices are described herein that include radially expandable and collapsible proximal and distal end portions, such as annular self-expanding stents or frames, that are configured to radially expand within an aorta to secure the device within the aorta. The devices can also include a catheter extending axially between the distal end portion and the proximal end portion and a porous covering, or filter, positioned around the catheter and between the proximal end portion and the distal end portion and configured to filter emboli from blood flowing into upper-body arteries. The device can further include a one-way valve positioned at or adjacent to the distal end portion of the device and configured to restrict retrograde blood flow through the device toward the heart.
    Type: Grant
    Filed: November 16, 2018
    Date of Patent: June 2, 2020
    Assignee: Edwards Lifesciences Corporation
    Inventors: Mark M. Dehdashtian, Teodoro S. Jimenez, Nathan Satter, Fabian Daniel Schroeder, Raffaele Mazzei, Jeff Kosmoski, Shahram Zamani, Adam J. Yestrepsky
  • Patent number: 10624743
    Abstract: Methods and devices for the treatment of cardiac valve dysfunction through the placement of lines and anchors. The lines and anchors can form artificial chordae between valve leaflets and the ventricular wall or papillary muscles or connect the two valve leaflets together. The methods and devices offer a mechanism for performing this technique with the heart still beating, and allows for the placement of multiple lines with a single device.
    Type: Grant
    Filed: April 19, 2017
    Date of Patent: April 21, 2020
    Assignee: Edwards Lifesciences Corporation
    Inventors: Yaron Keidar, Adam J. Yestrepsky
  • Publication number: 20200069426
    Abstract: Systems, apparatuses, and methods disclosed herein are provided for medical treatment, including transcatheter medical treatments and/or for treatment of dilated hearts (e.g., dilated left ventricle) or functional mitral valve regurgitation within a human heart. The systems, apparatuses, and methods disclosed herein may include applying one or more heart splints to the patient's heart to apply pressure to the heart to reshape the heart. Anchors disclosed herein may be utilized in plugs for treating openings in a septum between two chambers of a heart, e.g., ventricular septal defects (VSD), atrial septal defects (ASD), and patent foramen ovale (PFO). In addition, the anchors disclosed herein may be utilized to reshape an annulus of a patient's heart valve, including a tricuspid valve of a patient's heart. The anchors disclosed herein may also be utilized to reposition a heart valve leaflet to reduce heart valve leaflet prolapse.
    Type: Application
    Filed: August 23, 2019
    Publication date: March 5, 2020
    Inventors: Brian S. Conklin, Maria L. Saravia, Adam J. Yestrepsky, Derrick Johnson, Rodolfo Rodriguez, Sai Prasad Uppalapati, Louis A. Campbell
  • Publication number: 20190380835
    Abstract: A method for repairing a native valve of a patient during a non-open-heart procedure includes attaching two or more attachment members to the native valve. The method also includes applying a force to the two or more attachment members such that the two or more attachment members cause a cinching effect on at least a portion of the native valve. The method further includes securing the two or more attachment members with one or more anchor members such that the two or more attachment members maintain the cinching effect.
    Type: Application
    Filed: June 3, 2019
    Publication date: December 19, 2019
    Inventors: Sven Benjamin Iversen, Adam J. Yestrepsky, Amy E. Munnelly, Bin Tian, Danny Barrientos Baldo, JR., Brian S. Conklin, Louis A. Campbell, John Richard Carpenter
  • Publication number: 20190307991
    Abstract: An aortic occlusion and perfusion device includes an expandable member configured to expand within the aorta to secure the device within the aorta, and a catheter extending proximally from the expandable member and in fluid communication with the expandable member. The catheter can define a plurality of openings along its length through which blood can pass with one or more of the openings located proximal to the expandable member and one or more of the openings located within the expandable member. The device can also include a flow control sheath disposed around the catheter member such that axial movement of the flow control sheath relative to the catheter selectively occludes or uncovers one or more of the openings located proximal to the expandable member.
    Type: Application
    Filed: June 24, 2019
    Publication date: October 10, 2019
    Inventors: Kenneth Eliasen, Adam J. Yestrepsky
  • Patent number: 10328244
    Abstract: This disclosure relates generally to systems and methods for occluding vessels of the heart and inducing cardioplegic arrest to facilitate the performance of cardiac procedures. An aortic occlusion and perfusion device includes an expandable member configured to expand within the aorta to secure the device within the aorta, and a catheter extending proximally from the expandable member and in fluid communication with the expandable member. The catheter can define a plurality of openings along its length through which blood can pass with one or more of the openings located proximal to the expandable member and one or more of the openings located within the expandable member. The device can also include a flow control sheath disposed around the catheter member such that axial movement of the flow control sheath relative to the catheter selectively occludes or uncovers one or more of the openings located proximal to the expandable member.
    Type: Grant
    Filed: June 24, 2015
    Date of Patent: June 25, 2019
    Assignee: Edwards Lifesciences Corporation
    Inventors: Kenneth Eliasen, Adam J. Yestrepsky
  • Publication number: 20190083102
    Abstract: Embodiments of aortic occlusion devices are described herein that include radially expandable and collapsible proximal and distal end portions, such as annular self-expanding stents or frames, that are configured to radially expand within an aorta to secure the device within the aorta. The devices can also include a catheter extending axially between the distal end portion and the proximal end portion and a porous covering, or filter, positioned around the catheter and between the proximal end portion and the distal end portion and configured to filter emboli from blood flowing into upper-body arteries. The device can further include a one-way valve positioned at or adjacent to the distal end portion of the device and configured to restrict retrograde blood flow through the device toward the heart.
    Type: Application
    Filed: November 16, 2018
    Publication date: March 21, 2019
    Inventors: Mark M. Dehdashtian, Jorge H. Jimenez, Nathan Satter, Fabian Daniel Schroeder, Raffaele Mazzei, Jeff Kosmoski, Shahram Zamani, Adam J. Yestrepsky
  • Publication number: 20170304050
    Abstract: Methods and devices for the treatment of cardiac valve dysfunction through the placement of lines and anchors. The lines and anchors can form artificial chordae between valve leaflets and the ventricular wall or papillary muscles or connect the two valve leaflets together. The methods and devices offer a mechanism for performing this technique with the heart still beating, and allows for the placement of multiple lines with a single device.
    Type: Application
    Filed: April 19, 2017
    Publication date: October 26, 2017
    Inventors: Yaron Keidar, Adam J. Yestrepsky
  • Publication number: 20160158506
    Abstract: This disclosure relates generally to systems and methods for occluding vessels of the heart and inducing cardioplegic arrest to facilitate the performance of cardiac procedures. An aortic occlusion and perfusion device includes an expandable member configured to expand within the aorta to secure the device within the aorta, and a catheter extending proximally from the expandable member and in fluid communication with the expandable member. The catheter can define a plurality of openings along its length through which blood can pass with one or more of the openings located proximal to the expandable member and one or more of the openings located within the expandable member. The device can also include a flow control sheath disposed around the catheter member such that axial movement of the flow control sheath relative to the catheter selectively occludes or uncovers one or more of the openings located proximal to the expandable member.
    Type: Application
    Filed: June 24, 2015
    Publication date: June 9, 2016
    Applicant: Edwards Lifesciences Corporation
    Inventors: Kenneth Eliasen, Adam J. Yestrepsky